Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $3.62B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 2,077,200 | $225M | 6.2% | $76.12 | +16.8% | COM | 00287Y109 |
| AZN | ASTRAZENECA PLC | 3,650,500 | $182M | 5.0% | $49.89 | — | SPONSORED ADR | 046353108 |
| AVTR | AVANTOR INC | 4,985,100 | $144M | 4.0% | $21.20 | +36.1% | COM | 05352A100 |
| MDT | MEDTRONIC PLC | 1,024,200 | $121M | 3.3% | $97.44 | +4.4% | SHS | G5960L103 |
| ARVN | ARVINAS INC | 1,760,300 | $116M | 3.2% | $38.45 | +99.0% | COM | 04335A105 |
| ISRG | INTUITIVE SURGICAL INC | 139,400 | $103M | 2.8% | $251.58 | 0.0% | COM NEW | 46120E602 |
| MRVI | MARAVAI LIFESCIENCES HLDGS I | 2,761,545 | $98.42M | 2.7% | $27.85 | +19.0% | COM CL A | 56600D107 |
| CAH | CARDINAL HEALTH INC | 1,463,000 | $88.88M | 2.5% | $47.07 | +3.9% | COM | 14149Y108 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3,846,000 | $86M | 2.4% | $18.34 | +23.2% | COM | 87164F105 |
| — | ESSA PHARMA INC | 2,840,000 | $82.5M | 2.3% | $9.93 | — | COM NEW | 29668H708 |
| — | MIRATI THERAPEUTICS INC | 475,700 | $81.49M | 2.3% | $178.94 | — | COM | 60468T105 |
| — | SEAGEN INC | 577,900 | $80.25M | 2.2% | $138.86 | — | COM | 81181C104 |
| EXAS | EXACT SCIENCES CORP | 598,000 | $78.8M | 2.2% | $130.29 | +5.1% | COM | 30063P105 |
| NUVB | NUVATION BIO INC | 7,521,941 | $78.6M | 2.2% | $11.18 | 0.0% | COM CL A | 67080N101 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 1,049,800 | $71.75M | 2.0% | $62.35 | — | COM | G11196105 |
| VRTX | VERTEX PHARMACEUTICALS INC | 310,900 | $66.81M | 1.8% | $224.29 | -2.1% | COM | 92532F100 |
| NBP | I MAB | 1,329,000 | $64.42M | 1.8% | $47.05 | — | SPONSORED ADS | 44975P103 |
| — | ARENA PHARMACEUTICALS INC | 898,550 | $62.35M | 1.7% | $74.53 | — | COM NEW | 040047607 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 427,969 | $60.42M | 1.7% | $150.49 | 0.0% | COM | 02043Q107 |
| BHC | BAUSCH HEALTH COS INC | 1,891,300 | $60.03M | 1.7% | $18.65 | +57.2% | COM | 071734107 |
| — | CATALENT INC | 560,000 | $58.97M | 1.6% | $94.11 | — | COM | 148806102 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 1,263,300 | $54.81M | 1.5% | $39.46 | +9.1% | COM | 98943L107 |
| — | HORIZON THERAPEUTICS PUB L | 581,000 | $53.48M | 1.5% | $60.07 | — | SHS | G46188101 |
| — | BLUEPRINT MEDICINES CORP | 546,000 | $53.09M | 1.5% | $103.79 | — | COM | 09627Y109 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 326,000 | $52.19M | 1.4% | $148.71 | 0.0% | COM | 98956P102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 521,400 | $50.71M | 1.4% | $100.10 | +4.8% | COM | 64125C109 |
| BBIO | BRIDGEBIO PHARMA INC | 815,100 | $50.21M | 1.4% | $65.42 | 0.0% | COM | 10806X102 |
| — | CHEMOCENTRYX INC | 940,800 | $48.21M | 1.3% | $59.83 | — | COM | 16383L106 |
| — | ACCELERON PHARMA INC | 322,800 | $43.77M | 1.2% | $128.51 | — | COM | 00434H108 |
| — | TRILLIUM THERAPEUTICS INC | 4,015,000 | $43.12M | 1.2% | $13.67 | — | COM NEW | 89620X506 |
| — | ABIOMED INC | 132,500 | $42.23M | 1.2% | $318.73 | — | COM | 003654100 |
| NTRA | NATERA INC | 395,600 | $40.17M | 1.1% | $56.85 | +92.7% | COM | 632307104 |
| STTK | SHATTUCK LABS INC | 1,330,385 | $38.9M | 1.1% | $35.05 | +19.9% | COM | 82024L103 |
| — | INOVIO PHARMACEUTICALS INC | 4,004,391 | $37.16M | 1.0% | $9.28 | — | COM NEW | 45773H201 |
| — | KADMON HLDGS INC | 9,544,200 | $37.13M | 1.0% | $4.49 | — | COM | 48283N106 |
| ATEC | ALPHATEC HLDGS INC | 2,334,000 | $36.85M | 1.0% | $11.63 | +35.3% | COM NEW | 02081G201 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 523,100 | $35.75M | 1.0% | — | — | Call | G11196905 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,472,000 | $34.59M | 1.0% | $19.31 | 0.0% | COM | 45166A102 |
| — | DYNAVAX TECHNOLOGIES CORP | 3,500,000 | $34.41M | 1.0% | $4.21 | — | COM NEW | 268158201 |
| CI | CIGNA CORP NEW | 135,000 | $32.63M | 0.9% | $204.18 | 0.0% | COM | 125523100 |
| — | ORCHARD THERAPEUTICS PLC | 4,317,800 | $31.35M | 0.9% | $7.26 | — | ADS | 68570P101 |
| — | ATHIRA PHARMA INC | 1,677,845 | $30.87M | 0.9% | $18.60 | — | COM | 04746L104 |
| ALDX | ALDEYRA THERAPEUTICS INC | 2,552,000 | $30.32M | 0.8% | $8.67 | +32.8% | COM | 01438T106 |
| CGEM | CULLINAN ONCOLOGY INC | 707,359 | $29.48M | 0.8% | $40.60 | 0.0% | COM | 230031106 |
| — | HARPOON THERAPEUTICS INC | 1,408,000 | $29.45M | 0.8% | $18.51 | — | COM | 41358P106 |
| — | ADICET BIO INC | 2,230,000 | $29.17M | 0.8% | $13.08 | — | COM | 007002108 |
| SHC | SOTERA HEALTH CO | 1,161,000 | $28.98M | 0.8% | $26.69 | -0.9% | COM | 83601L102 |
| ORGO | ORGANOGENESIS HLDGS INC | 1,463,403 | $26.66M | 0.7% | $4.75 | +185.3% | COM | 68621F102 |
| — | BELLUS HEALTH INC NEW | 6,797,400 | $26.1M | 0.7% | $3.18 | — | COM NEW | 07987C204 |
| — | KINIKSA PHARMACEUTICALS LTD | 1,330,700 | $24.63M | 0.7% | $17.90 | — | COM CL A | G5269C101 |
| SANA | SANA BIOTECHNOLOGY INC | 732,321 | $24.51M | 0.7% | $32.56 | 0.0% | COM | 799566104 |
| IMCR | IMMUNOCORE HLDGS PLC | 550,000 | $23.41M | 0.6% | $42.57 | — | ADS | 45258D105 |
| — | CURIS INC | 2,053,789 | $23.25M | 0.6% | $8.19 | — | COM NEW | 231269200 |
| AUPH | AURINIA PHARMACEUTICALS INC | 1,784,000 | $23.16M | 0.6% | $15.54 | -6.6% | COM | 05156V102 |
| CRDF | CARDIFF ONCOLOGY INC | 2,447,700 | $22.67M | 0.6% | $15.71 | -22.7% | COM | 14147L108 |
| — | IGM BIOSCIENCES INC | 293,000 | $22.47M | 0.6% | $79.86 | — | COM | 449585108 |
| — | BOLT BIOTHERAPEUTICS INC | 654,294 | $21.53M | 0.6% | $32.91 | — | COM | 097702104 |
| — | CHIMERIX INC | 2,230,000 | $21.5M | 0.6% | $9.64 | — | COM | 16934W106 |
| — | GRITSTONE ONCOLOGY INC | 2,122,064 | $20.01M | 0.6% | $3.94 | — | COM | 39868T105 |
| BVS | BIOVENTUS INC | 1,254,333 | $19.17M | 0.5% | $14.24 | 0.0% | COM CL A | 09075A108 |
| — | SIGILON THERAPEUTICS INC | 850,968 | $19.02M | 0.5% | $43.11 | — | COM | 82657L107 |
| SIBN | SI BONE INC | 577,570 | $18.37M | 0.5% | $24.35 | +26.3% | COM | 825704109 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 740,000 | $17.54M | 0.5% | $18.33 | +29.6% | COM | 19459J104 |
| — | ONCOSEC MED INC | 3,470,000 | $16.55M | 0.5% | $5.71 | — | COM | 68234L306 |
| — | ALPINE IMMUNE SCIENCES INC | 1,511,000 | $16.02M | 0.4% | $10.21 | — | COM | 02083G100 |
| — | PHASEBIO PHARMACEUTICALS INC | 4,285,000 | $14.83M | 0.4% | $3.46 | — | COM | 717224109 |
| — | KEZAR LIFE SCIENCES INC | 1,907,081 | $11.37M | 0.3% | $5.96 | — | COM | 49372L100 |
| PHVS | PHARVARIS N V | 400,000 | $11.19M | 0.3% | $31.46 | 0.0% | COM | N69605108 |
| — | ADAMAS PHARMACEUTICALS INC | 2,200,200 | $10.56M | 0.3% | $4.80 | — | COM | 00548A106 |
| — | AFFIMED N V | 1,296,000 | $10.25M | 0.3% | $7.91 | — | COM | N01045108 |
| — | MERUS N V | 487,000 | $10.17M | 0.3% | $20.89 | — | COM | N5749R100 |
| SCYX | SCYNEXIS INC | 1,263,769 | $10.03M | 0.3% | $5.86 | +40.0% | COM NEW | 811292200 |
| — | INSTIL BIO INC | 400,000 | $10.03M | 0.3% | $25.08 | — | COM | 45783C101 |
| IMTX | IMMATICS N.V | 884,600 | $9.916M | 0.3% | $11.34 | 0.0% | SHS | N44445109 |
| TERN | TERNS PHARMACEUTICALS INC | 400,000 | $8.8M | 0.2% | $21.92 | 0.0% | COM | 880881107 |
| — | EVELO BIOSCIENCES INC | 800,000 | $8.56M | 0.2% | $10.70 | — | COM | 299734103 |
| — | CM LIFE SCIENCES INC | 550,000 | $8.19M | 0.2% | $14.89 | — | COM CL A | 18978W109 |
| — | VESPER HEALTHCARE ACQSTN COR | 600,000 | $6.93M | 0.2% | $10.26 | — | UNIT 99/99/9999 | 92538T203 |
| — | ARYA SCIENCES ACQUISITION CO | 500,000 | $6.89M | 0.2% | $10.85 | — | COM CL A | G3166W106 |
| ARGX | ARGENX SE | 20,000 | $5.508M | 0.2% | $275.40 | — | SPONSORED ADR | 04016X101 |
| — | BCLS ACQUISITION CORP | 500,000 | $5.285M | 0.1% | $11.14 | — | COM CL A | G0904B105 |
| — | ARYA SCIENCES ACQU CORP IV | 500,000 | $5.236M | 0.1% | $10.47 | — | CL A | G31659108 |
| — | MEDICUS SCIENCES ACQUISITION | 520,000 | $5.122M | 0.1% | $9.85 | — | UNIT 99/99/9999 | G5960S116 |
| HYPR | HEALTHCOR CATALIO ACQU CORP | 500,000 | $5M | 0.1% | $10.00 | — | CL A SHS | G44125105 |
| — | HEALTH SCIENCES ACQ CORP 2 | 400,000 | $4.476M | 0.1% | $11.00 | — | ORD SHS | G4411D109 |
| — | CM LIFE SCIENCES II INC | 336,700 | $4.31M | 0.1% | $12.80 | — | UNIT 02/25/2028 | 125842203 |
| MLTX | HELIX ACQUISITION CORP | 400,000 | $4.08M | 0.1% | $11.37 | — | COM CL A | G4444C102 |
| — | LIFESCI ACQUISITION II CORP | 400,000 | $4.056M | 0.1% | $10.67 | — | COM | 53229E103 |
| COGT | COGENT BIOSCIENCES INC | 417,710 | $3.667M | 0.1% | $10.99 | -12.4% | COM | 19240Q201 |
| — | BCTG ACQUISITION CORP | 300,000 | $3.336M | 0.1% | $10.36 | — | COM | 05492W103 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 232,504 | $2.362M | 0.1% | $11.25 | 0.0% | COM NEW | 30233G209 |
| ANNX | ANNEXON INC | 70,000 | $1.949M | 0.1% | $24.52 | +12.2% | COM | 03589W102 |
| — | AMERICAN WELL CORP | 70,250 | $1.22M | 0.0% | $26.10 | — | CL A | 03044L105 |
| — | NUVATION BIO INC | 99,999 | $267K | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |